Condensed Consolidated Statements Of Shareholders' Equity - USD ($) $ in Millions | Total | Common Stock [Member] | Accumulated Deficit [Member] | Accumulated Other Comprehensive Loss [Member] |
Common stock, balance, beginning of period at Jan. 30, 2021 | | $ 3,205 | | |
Common stock | | | | |
Issuance of common stock under stock compensation plans | | 7 | | |
Stock-based compensation | | 33 | | |
Common stock, balance, end of period at Jul. 31, 2021 | $ 3,245 | 3,245 | | |
Accumulated deficit, balance, beginning of period at Jan. 30, 2021 | | | $ (2,830) | |
Accumulated deficit | | | | |
Net earnings (loss) | (86) | | (86) | |
Dividends | | | 0 | |
Repurchase of common stock | 0 | | 0 | |
Accumulated deficit, balance, end of period at Jul. 31, 2021 | (2,916) | | (2,916) | |
Accumulated other comprehensive loss, balance, beginning of period at Jan. 30, 2021 | | | | $ (70) |
Accumulated other comprehensive loss | | | | |
Other comprehensive (loss) income | | | | 9 |
Accumulated other comprehensive loss, balance, end of period at Jul. 31, 2021 | (61) | | | (61) |
Total shareholders’ equity at Jul. 31, 2021 | $ 268 | | | |
Accumulated other comprehensive loss | | | | |
Dividends per share | $ 0 | | | |
Common stock, balance, beginning of period at May. 01, 2021 | | 3,221 | | |
Common stock | | | | |
Issuance of common stock under stock compensation plans | | 0 | | |
Stock-based compensation | | 24 | | |
Common stock, balance, end of period at Jul. 31, 2021 | $ 3,245 | 3,245 | | |
Accumulated deficit, balance, beginning of period at May. 01, 2021 | | | (2,996) | |
Accumulated deficit | | | | |
Net earnings (loss) | 80 | | 80 | |
Dividends | | | 0 | |
Repurchase of common stock | | | 0 | |
Accumulated deficit, balance, end of period at Jul. 31, 2021 | (2,916) | | (2,916) | |
Accumulated other comprehensive loss, balance, beginning of period at May. 01, 2021 | | | | (59) |
Accumulated other comprehensive loss | | | | |
Other comprehensive (loss) income | | | | (2) |
Accumulated other comprehensive loss, balance, end of period at Jul. 31, 2021 | (61) | | | (61) |
Total shareholders’ equity at Jul. 31, 2021 | $ 268 | | | |
Accumulated other comprehensive loss | | | | |
Dividends per share | $ 0 | | | |
Common stock, balance, beginning of period at Jan. 29, 2022 | $ 3,283 | 3,283 | | |
Common stock | | | | |
Issuance of common stock under stock compensation plans | | 9 | | |
Stock-based compensation | | 22 | | |
Common stock, balance, end of period at Jul. 30, 2022 | 3,314 | 3,314 | | |
Accumulated deficit, balance, beginning of period at Jan. 29, 2022 | (2,652) | | (2,652) | |
Accumulated deficit | | | | |
Net earnings (loss) | 146 | | 146 | |
Dividends | | | (60) | |
Repurchase of common stock | (35) | | (35) | |
Accumulated deficit, balance, end of period at Jul. 30, 2022 | (2,601) | | (2,601) | |
Accumulated other comprehensive loss, balance, beginning of period at Jan. 29, 2022 | (50) | | | (50) |
Accumulated other comprehensive loss | | | | |
Other comprehensive (loss) income | | | | 0 |
Accumulated other comprehensive loss, balance, end of period at Jul. 30, 2022 | (50) | | | (50) |
Total shareholders’ equity at Jul. 30, 2022 | $ 663 | | | |
Accumulated other comprehensive loss | | | | |
Dividends per share | $ 0.38 | | | |
Common stock, balance, beginning of period at Apr. 30, 2022 | | 3,301 | | |
Common stock | | | | |
Issuance of common stock under stock compensation plans | | 1 | | |
Stock-based compensation | | 12 | | |
Common stock, balance, end of period at Jul. 30, 2022 | $ 3,314 | $ 3,314 | | |
Accumulated deficit, balance, beginning of period at Apr. 30, 2022 | | | (2,662) | |
Accumulated deficit | | | | |
Net earnings (loss) | 126 | | 126 | |
Dividends | | | (30) | |
Repurchase of common stock | | | (35) | |
Accumulated deficit, balance, end of period at Jul. 30, 2022 | (2,601) | | $ (2,601) | |
Accumulated other comprehensive loss, balance, beginning of period at Apr. 30, 2022 | | | | (50) |
Accumulated other comprehensive loss | | | | |
Other comprehensive (loss) income | | | | 0 |
Accumulated other comprehensive loss, balance, end of period at Jul. 30, 2022 | (50) | | | $ (50) |
Total shareholders’ equity at Jul. 30, 2022 | $ 663 | | | |
Accumulated other comprehensive loss | | | | |
Dividends per share | $ 0.19 | | | |